These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Editorial: One small step for metaplasia, but one giant leap for biomarkers is needed. Nicholson A, Jankowski J. Am J Gastroenterol; 2009 Nov 01; 104(11):2681-3. PubMed ID: 19888234 [Abstract] [Full Text] [Related]
10. Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options. Neumann H, Mönkemüller K, Vieth M, Malfertheiner P. Dig Dis; 2009 Nov 01; 27(1):18-23. PubMed ID: 19439956 [Abstract] [Full Text] [Related]
14. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Rygiel AM, Milano F, Ten Kate FJ, Schaap A, Wang KK, Peppelenbosch MP, Bergman JJ, Krishnadath KK. Cancer Epidemiol Biomarkers Prev; 2008 Jun 01; 17(6):1380-5. PubMed ID: 18559552 [Abstract] [Full Text] [Related]
15. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus. Asthana N, Mandich D, Ligato S. Am J Surg Pathol; 2008 Oct 01; 32(10):1581-5. PubMed ID: 18724240 [Abstract] [Full Text] [Related]
16. Correspondence re: R. Kim et al., Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol., Biomark. Prev., 6: 369-377, 1997. Morgan G. Cancer Epidemiol Biomarkers Prev; 1998 Mar 01; 7(3):265. PubMed ID: 9521445 [No Abstract] [Full Text] [Related]